Alector Inc. cuts its workforce by nearly 50% following the failure of its dementia drug trial, signalling challenges in the ...

A massive genetic study found that naturally lower cholesterol is linked to a dramatically reduced risk of dementia. The ...

A Southport cancer survivor and a Florida man fighting Alzheimer's are among inspiring athletes competing in Saturday's ...

Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found ...

"For the first time, we found that empagliflozin, an established diabetes and heart medication, reduced markers of brain ...

The first time Joey Carlsen Martinez came to Memorial Sloan Kettering Cancer Center (MSK), he was in terrible shape. He had a ...

Farmington Hills, Michigan, Oct. 23, 2025 (GLOBE NEWSWIRE) -- “We made every effort to bring this treatment to U.S. patients first,” said Cerezen Founder and CEO Manoj Bhargava. “However, it seems ...

The firm's monoclonal antibody latozinemab did not slow disease progression in patients with dementia due to progranulin gene mutations.

The Burlington, N.C., lab-services company on Thursday said the Elecsys pTau181 test, developed by Swiss drugmaker Roche Holding and approved for commercialization by the U.S. Food and Drug ...

Potomac-based IGC Pharma Inc. has been selected as a semifinalist in the prestigious $1 million Alzheimer's Insights AI Prize ...

The negative readout led to a collapse in share price for Alector, which now plans to cut almost half of its workforce while ...